An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo.

Abstract:

:High frequencies of allelic loss on the short arm of chromosome 3 in small cell lung cancer (SCLC) and a number of other tumors suggest the existence of a tumor suppressor gene(s) within the deleted regions. Two small cell lung cancer lines, NCI H740 and GLC20, have been described which have homozygous deletions in the region 3p21.3. The deleted region overlaps with a 2 Mb fragment of human DNA present in the interspecies hybrid HA(3)BB9F, that suppresses tumor formation by mouse A9 fibrosarcoma cells. Human sequences from this cell hybrid were isolated using inter Alu PCR. From this starting point, a P1 contig was developed for the region of 450 Kb that is common to the homozygous deletions seen in the SCLC lines NCI H740 and GLC20 and is also present in HA(3)BB9F, the suppressed A9 hybrid. Individual P1 clones were assayed for their ability to suppress the tumorigenicity of the mouse fibrosarcoma cell line A9 as assayed by injection of transfected A9 cells into athymic nude mice. The introduction of one of the P1 clones into A9 cells resulted in suppression of tumor growth whereas two other P1 clones from the contig failed to suppress tumor formation in athymic nude mice. These data functionally delimit a tumor suppressor locus to a region of 80 kb within a P1 clone at 3p21.3.

journal_name

Oncogene

journal_title

Oncogene

authors

Todd MC,Xiang RH,Garcia DK,Kerbacher KE,Moore SL,Hensel CH,Liu P,Siciliano MJ,Kok K,van den Berg A,Veldhuis P,Buys CH,Killary AM,Naylor SL

subject

Has Abstract

pub_date

1996-12-05 00:00:00

pages

2387-96

issue

11

eissn

0950-9232

issn

1476-5594

journal_volume

13

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.

    abstract::Mice transgenic for the leukemia oncogene E2A-PBX1 invariably develop lethal, high-grade T-cell lymphomas by 5 months of age. In this study, retroviral insertional mutagenesis was employed to identify oncogenes that cooperate with the E2A-PBX1 transgene in lymphomagenesis. Neonatal retroviral infection substantially r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201670

    authors: Feldman BJ,Reid TR,Cleary ML

    更新日期:1997-11-27 00:00:00

  • Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.

    abstract::Adhesion to the extracellular matrix (ECM) is critical for epithelial tissue homeostasis and function. ECM detachment induces metabolic stress and programmed cell death via anoikis. ECM-detached mammary epithelial cells are able to rapidly activate autophagy allowing for survival and an opportunity for re-attachment. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.512

    authors: Avivar-Valderas A,Bobrovnikova-Marjon E,Alan Diehl J,Bardeesy N,Debnath J,Aguirre-Ghiso JA

    更新日期:2013-10-10 00:00:00

  • The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.

    abstract::The recepteur d'origine nantais (RON) is a receptor tyrosine kinase (RTK) in the scatter factor family, which includes the c-Met receptor. RON exhibits increased expression in a significant number of human breast cancer tissues as well as in many established breast cancer cell lines. Recent studies have indicated that...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.383

    authors: Feres KJ,Ischenko I,Hayman MJ

    更新日期:2009-01-15 00:00:00

  • Cloning and sequencing of the human c-abl 3' untranslated region.

    abstract::The human c-abl oncogene gives rise to different mRNA transcripts which vary primarily in that they possess alternative first exons. In the present study, we present the sequence for the human c-abl 3' untranslated region (3'utr) and show that while human and murine c-abl cDNA sequences are generally homologous, human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Andrews DF 3rd,Tompkins CK,Hendrickson SL,Singer JW

    更新日期:1990-03-01 00:00:00

  • Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

    abstract::Proteinase-activated receptor 2 (PAR2) is a G protein-coupled receptor that is activated by trypsin-like proteinases. PAR2 is detected in breast tumor specimens; however, it is not clear how PAR2 level in breast cancer cell/tissues compares with normal cell/tissues. Here, we show the elevation of PAR2 protein level in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.163

    authors: Su S,Li Y,Luo Y,Sheng Y,Su Y,Padia RN,Pan ZK,Dong Z,Huang S

    更新日期:2009-08-27 00:00:00

  • The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.

    abstract::Thrombospondin-1 (TSP-1) is an endogenous inhibitor of angiogenesis whose expression suppresses tumor growth in vivo. Like many angiogenesis-related genes, TSP-1 expression is tightly controlled by various mechanisms, but there is little data regarding the contribution of post-transcriptional processing to this regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.464

    authors: Doçi CL,Zhou G,Lingen MW

    更新日期:2013-09-12 00:00:00

  • TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA.

    abstract::The cancer-prone and premature aging disease Werner syndrome is due to loss of WRN gene function. Cells lacking WRN demonstrate genomic instability, including telomeric abnormalities and undergo premature senescence, suggesting defects in telomere metabolism. This notion is strongly supported by our finding of physica...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206906

    authors: Machwe A,Xiao L,Orren DK

    更新日期:2004-01-08 00:00:00

  • RNH1 regulation of reactive oxygen species contributes to histone deacetylase inhibitor resistance in gastric cancer cells.

    abstract::Histone deacetylase inhibitors (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a panel of 17 gastric...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.104

    authors: Zhu Y,Das K,Wu J,Lee MH,Tan P

    更新日期:2014-03-20 00:00:00

  • The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.

    abstract::Inter-alpha-trypsin inhibitors (ITIs) are protease inhibitors stabilizing the extracellular matrix. ITIs consist of one light (bikunin) and two heavy chains (ITIHs). We have recently characterized ITIH5, a novel member of the ITIH gene family, and showed that its messenger RNA is lost in a high proportion of breast tu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210669

    authors: Veeck J,Chorovicer M,Naami A,Breuer E,Zafrakas M,Bektas N,Dürst M,Kristiansen G,Wild PJ,Hartmann A,Knuechel R,Dahl E

    更新日期:2008-01-31 00:00:00

  • RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.

    abstract::Osteopontin (OPN) is a phosphorylated glycoprotein that binds to alpha v-containing integrins and is important in malignant transformation and cancer. Previously, we have utilized suppressive subtractive hybridization between mRNAs isolated from the Rama 37 (R37) rat mammary cell line and a subclone rendered invasive ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.325

    authors: Kurisetty VV,Johnston PG,Johnston N,Erwin P,Crowe P,Fernig DG,Campbell FC,Anderson IP,Rudland PS,El-Tanani MK

    更新日期:2008-12-04 00:00:00

  • Interplay between ATM and ATR in the regulation of common fragile site stability.

    abstract::Common fragile sites are specific genomic loci that form constrictions and gaps on metaphase chromosomes under conditions that slow, but do not arrest, DNA replication. These sites have been shown to have a role in various chromosomal rearrangements in tumors. Different DNA damage response proteins were shown to regul...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210849

    authors: Ozeri-Galai E,Schwartz M,Rahat A,Kerem B

    更新日期:2008-04-03 00:00:00

  • Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.

    abstract::Somatic alterations of fibroblast growth factor receptors (FGFRs) have been described in a wide range of malignancies. A number of anti-FGFR therapies are currently under investigation in clinical trials for subjects with FGFR gene amplifications, mutations and translocations. Here, we develop cell line models of acqu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.161

    authors: Wang J,Mikse O,Liao RG,Li Y,Tan L,Janne PA,Gray NS,Wong KK,Hammerman PS

    更新日期:2015-04-23 00:00:00

  • The oncogene PDGF-B provides a key switch from cell death to survival induced by TNF.

    abstract::Tumor necrosis factor (TNF) induces both cell death and survival signals. NF-kappaB, a transcription factor activated by TNF, is critical for controlling survival signals through trans-activation of downstream target genes. However, few NF-kappaB target survival genes have been identified with direct roles in oncogene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208516

    authors: Au PY,Martin N,Chau H,Moemeni B,Chia M,Liu FF,Minden M,Yeh WC

    更新日期:2005-04-28 00:00:00

  • Genetics of melanoma predisposition.

    abstract::Predisposition to melanoma is genetically heterogeneous. Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others. With the advent of a catalogue of millions of potential DNA polymorphisms, attention is now also being focused on ident...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206445

    authors: Hayward NK

    更新日期:2003-05-19 00:00:00

  • Mysterious liaisons: the relationship between c-Myc and the cell cycle.

    abstract::A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202749

    authors: Obaya AJ,Mateyak MK,Sedivy JM

    更新日期:1999-05-13 00:00:00

  • aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.

    abstract::Atypical protein kinase C (aPKC) and Lethal giant larvae (Lgl) regulate apical-basal polarity in Drosophila and mammalian epithelia. At the apical domain, aPKC phosphorylates and displaces Lgl that, in turn, maintains aPKC inactive at the basolateral region. The mutual exclusion of these two proteins seems to be cruci...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210389

    authors: Grifoni D,Garoia F,Bellosta P,Parisi F,De Biase D,Collina G,Strand D,Cavicchi S,Pession A

    更新日期:2007-08-30 00:00:00

  • The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.

    abstract::The BTB/POZ family of proteins has been implicated in multiple biological processes, including tumourigenesis, DNA damage responses and cell cycle progression and development. MIZ-1 (Myc-interacting zinc-finger protein 1) is known to activate transcription of CDKN1A. We recently found that a kidney cancer-related POK ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.331

    authors: Lee KM,Choi WI,Koh DI,Kim YJ,Jeon BN,Yoon JH,Lee CE,Kim SH,Oh J,Hur MW

    更新日期:2012-03-15 00:00:00

  • The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

    abstract::NIH sponsored a meeting of medical and veterinary pathologists with mammary gland expertise in Annapolis in March 1999. Rapid development of mouse mammary models has accentuated the need for definitions of the mammary lesions in genetically engineered mice (GEM) and to assess their usefulness as models of human breast...

    journal_title:Oncogene

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1038/sj.onc.1203277

    authors: Cardiff RD,Anver MR,Gusterson BA,Hennighausen L,Jensen RA,Merino MJ,Rehm S,Russo J,Tavassoli FA,Wakefield LM,Ward JM,Green JE

    更新日期:2000-02-21 00:00:00

  • Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.

    abstract::Prostate cancer is one of the major causes of cancer-related death in the western world. Androgen-deprivation therapy (ADT) for the suppression of androgens binding to the androgen receptor (AR) has been the norm of prostate cancer treatment. Despite early success to suppress prostate tumor growth, ADT eventually fail...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.121

    authors: Niu Y,Chang TM,Yeh S,Ma WL,Wang YZ,Chang C

    更新日期:2010-06-24 00:00:00

  • PKA signaling drives mammary tumorigenesis through Src.

    abstract::Protein kinase A (PKA) hyperactivation causes hereditary endocrine neoplasias; however, its role in sporadic epithelial cancers is unknown. Here, we show that heightened PKA activity in the mammary epithelium generates tumors. Mammary-restricted biallelic ablation of Prkar1a, which encodes for the critical type-I PKA ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.41

    authors: Beristain AG,Molyneux SD,Joshi PA,Pomroy NC,Di Grappa MA,Chang MC,Kirschner LS,Privé GG,Pujana MA,Khokha R

    更新日期:2015-02-26 00:00:00

  • Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.

    abstract::Silencing of the MLH1 gene by promoter hypermethylation is the mechanism underlying the microsatellite instability (MSI) phenotype in endometrial cancers. However, the profile of CpG methylation in a wide range of MLH1 promoters in endometrial cancers and in the normal endometrium is largely unknown. The present study...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206365

    authors: Kanaya T,Kyo S,Maida Y,Yatabe N,Tanaka M,Nakamura M,Inoue M

    更新日期:2003-04-17 00:00:00

  • The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.

    abstract::The orphan nuclear receptor TR3 (NR41A and Nur77) is overexpressed in most lung cancer patients and is a negative prognostic factor for patient survival. The function of TR3 was investigated in non-small-cell lung cancer A549 and H460 cells, and knockdown of TR3 by RNA interference (siTR3) inhibited cancer cell growth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.504

    authors: Lee SO,Andey T,Jin UH,Kim K,Singh M,Safe S

    更新日期:2012-07-05 00:00:00

  • Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12.

    abstract::A proportion of familial breast cancer has recently been shown by genetic linkage analysis to map to chromosome l3q12 (Wooster et al, 1994). This locus contains a tumor suppressor gene BRCA2, mutations in which lead to tumorigenesis. Genetic alterations at this locus have also been shown in pancreatic adenocarcinoma a...

    journal_title:Oncogene

    pub_type:

    doi:

    authors: Jacob AN,Kandpal G,Kandpal RP

    更新日期:1996-07-04 00:00:00

  • Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response.

    abstract::Ras is a major signaling molecule activated by interleukin-6. There have been no published reports, however, that specifically examine the kinetics and percentage of Ras activation in response to IL-6. Model cell lines were used to study activation of N- and K-ras induced by IL-6. All of the myeloma cell lines we test...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205387

    authors: Rowley M,Van Ness B

    更新日期:2002-12-12 00:00:00

  • High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.

    abstract::The few imprinted genes characterized so far include the insulin-like growth factor-2 gene (IGF2) coding for a foetal growth factor and the H19 gene whose normal function is unknown but which is likely to act as an RNA with an antitumour effect. IGF2 is expressed by the paternal allele and H19 by the maternal allele. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Douc-Rasy S,Barrois M,Fogel S,Ahomadegbe JC,Stéhelin D,Coll J,Riou G

    更新日期:1996-01-18 00:00:00

  • Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer.

    abstract::Resistance to anti-HER2 (human epithelial growth factor receptor 2) trastuzumab therapy occurs commonly in HER2-positive breast cancer and involves overactivation of HER2 and/or AKT1. Using the model of trastuzumab-sensitive or trastuzumab-resistant HER2-positive cells with wild-type PTEN, negative regulator of AKT1, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.422

    authors: Kulkarni S,Reddy KB,Esteva FJ,Moore HC,Budd GT,Tubbs RR

    更新日期:2010-03-04 00:00:00

  • The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.

    abstract::Tek/Tie2 is an endothelial cell-specific receptor tyrosine kinase that has been shown to play a role in vascular development of the mouse. Targeted mutagenesis of both Tek and its agonistic ligand, Angiopoietin-1, result in embryonic lethality, demonstrating that the signal transduction pathway(s) mediated by this rec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202115

    authors: Jones N,Dumont DJ

    更新日期:1998-09-03 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract::Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.221

    authors: Gonzalvez F,Ashkenazi A

    更新日期:2010-08-26 00:00:00

  • The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.

    abstract::BPV-4 E5 inhibits transcription of the bovine MHC class I heavy chain (HC) gene, increases degradation of HC and downregulates surface expression of MHC class I by retaining the complex in the Golgi apparatus (GA). Here we report that transcription inhibition can be alleviated by interferon treatment and the degradati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209245

    authors: Marchetti B,Ashrafi GH,Dornan ES,Araibi EH,Ellis SA,Campo MS

    更新日期:2006-04-06 00:00:00

  • The cyclin-dependent kinase inhibitor p27Kip1 is localized to the cytosol in Swiss/3T3 cells.

    abstract::p27Kip1 plays an important role in cell cycle progression by negatively regulating the activity of cyclin-Cdk complexes. To understand how p27Kip1 functions, the level and subcellular location of p27Kip1 in Swiss/3T3 cells following serum stimulation of quiescent cells was examined. Surprisingly, p27Kip1 was observed ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202912

    authors: Wang G,Miskimins R,Miskimins WK

    更新日期:1999-09-16 00:00:00